Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions

MenopauseTestosterone DeficiencyEstrogen Deficiency

Interventions

DRUG

testosterone pellet (100 mg)

Intervention arm: Subdermal implant-bioabsorbable testosterone pellet (100 mg of testosterone)

DRUG

Placebo

Pellet of cholesterol (placebo)

All Listed Sponsors

lead

University of Sao Paulo General Hospital

OTHER